SplitJun 10, 2026, 07:06 AM
Basel Medical Group Ltd to Effect 1-for-12 Reverse Share Split on June 22
AI Summary
Basel Medical Group Ltd announced its board of directors has approved a 1-for-12 reverse share split, effective June 22, 2026. This move aims to comply with Nasdaq Marketplace Rule 5550(a)(2) requiring a minimum bid price of $1 per share. The total number of outstanding ordinary shares will decrease from approximately 18.7 million to 1.5 million. The shares will continue to trade under the ticker BMGL but with a new CUSIP number.
Key Highlights
- Basel Medical Group Ltd approved a 1-for-12 reverse share split.
- The split is effective June 22, 2026, to comply with Nasdaq's minimum bid price rule.
- The number of outstanding shares will reduce from 18,785,750 to approximately 1,565,480.
- Ordinary shares will trade under the same symbol 'BMGL' with a new CUSIP number G0864B111.
- No fractional shares will be issued; shareholders will receive one whole share in lieu of fractions.
Price Impact
More from BMGL